Medline (NASDAQ:MDLN) Issues Earnings Results, Beats Expectations By $0.04 EPS

Medline (NASDAQ:MDLN) released its quarterly earnings results on Wednesday. The company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.04, FiscalAI reports. The firm had revenue of $7.35 billion for the quarter. The company’s quarterly revenue was up 10.7% on a year-over-year basis.

Here are the key takeaways from Medline’s conference call:

• Medline reported a strong start to 2026 with 11% top-line growth in Q1 and raised full‑year organic sales guidance to 8.5%–9.5%, driven by Supply Chain Solutions and new customer implementations.
• Adjusted EBITDA declined 11% to $776 million and margins fell ~250 bps, with management citing higher cost of goods (including tariff impact) and continued operational investments as the main drivers.
• Company flagged ongoing macro headwinds — tariff volatility and the Middle East conflict — that could raise input and fuel costs later in 2026 and may prompt measured price actions if needed.
• Strategic initiatives progressed: Medline secured its first Canadian prime‑vendor partnership with Mohawk Medbuy, began pilots of robotics with Symbotic, introduced automation (Pick Pack Pro) and is expanding its AI control tower Mpower, all intended to improve efficiency and drive future growth.
• Balance sheet and cash flow support investments — Q1 free cash flow of $316 million, $2.2 billion cash on hand and net leverage ~3.1x — and management said it will pursue strategic M&A or further deleveraging as opportunities arise.

Medline Stock Performance

Shares of MDLN traded down $3.31 during midday trading on Wednesday, hitting $42.01. The company had a trading volume of 18,289,073 shares, compared to its average volume of 4,829,894. The firm has a 50 day moving average price of $44.57. Medline has a 52 week low of $34.89 and a 52 week high of $50.88.

Analysts Set New Price Targets

MDLN has been the subject of several recent analyst reports. Wolfe Research began coverage on Medline in a research note on Monday, January 12th. They set an “outperform” rating and a $47.00 target price for the company. Wells Fargo & Company boosted their price target on Medline from $42.00 to $47.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. William Blair initiated coverage on Medline in a research note on Monday, January 12th. They set an “outperform” rating for the company. Morgan Stanley lifted their price objective on Medline from $48.00 to $52.00 and gave the stock an “overweight” rating in a report on Monday, March 2nd. Finally, Bank of America began coverage on Medline in a research report on Monday, January 12th. They issued a “buy” rating and a $50.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $50.62.

Hedge Funds Weigh In On Medline

A number of hedge funds have recently bought and sold shares of the company. Perigon Wealth Management LLC acquired a new stake in Medline during the fourth quarter valued at approximately $211,000. SteelPeak Wealth LLC acquired a new position in shares of Medline in the 4th quarter worth approximately $441,000. Sound Income Strategies LLC acquired a new position in shares of Medline in the 4th quarter worth approximately $25,000. Massachusetts Financial Services Co. MA bought a new stake in shares of Medline in the 4th quarter valued at approximately $429,544,000. Finally, Baillie Gifford & Co. acquired a new stake in shares of Medline during the 4th quarter valued at approximately $437,236,000.

Medline Company Profile

Medline (NASDAQ: MDLN) is a healthcare products and services company that manufactures, sources and distributes a wide range of medical supplies and equipment for healthcare providers. Its product portfolio spans clinical consumables and personal protective equipment, surgical and procedural supplies, wound care and incontinence products, diagnostic and laboratory supplies, and select durable medical equipment. Medline supports care settings that include hospitals, health systems, long-term care facilities, ambulatory clinics and home health providers.

In addition to product manufacturing and distribution, Medline provides supply‑chain and logistics services designed to help healthcare customers manage inventory, reduce costs and streamline operations.